U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07728695) titled 'Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain' on July 22.
Brief Summary: Despite recent increases in both medical and recreational cannabis use in the United States and globally, little research has been conducted to determine the potential applications for womens health. A variety of medical cannabis and hemp-derived products on the marketplace claim to hold efficacy for many womens health-related conditions, including gynecologic pain. This 7-day study of individuals living with endometriosis, adenomyosis, or chronic pelvic inflammatory disease (PID), will identify specific targets and me...